SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction
Vennela Avula, Garima Sharma, Mikhail Kosiborod, Muthiah Vaduganathan, Tomas G. Neilan, Teresa López‐Fernández, Susan Dent, Lauren A. Baldassarre, Marielle Scherrer‐Crosbie, Ana Barac, Jennifer Liu, Anita Deswal, Sumanth Khadke, Eric H. Yang, Bonnie Ky, Daniel J. Lenihan, Anju Nohria, Sourbha S. Dani, Sarju Ganatra
Topics & Concepts
MedicineHeart failureCardiac dysfunctionInternal medicineCancer therapyCancerCardiologyIntensive care medicineOncologyChemotherapy-induced cardiotoxicity and mitigationDiabetes Treatment and ManagementMetabolism, Diabetes, and Cancer